scorecardresearch
Friday, August 22, 2025
TopicAIDS

Topic: AIDS

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

Climate crisis could increase HIV infections and AIDS related deaths, UN warns

At the COP29 in Baku, UNAIDS and UNDP presented a report that highlights how climate change could exacerbate existing vulnerabilities to HIV.

More people dying from lack of access to antibiotics. It is leading to rise in drug resistance

By 2050, the total number of deaths associated with drug resistance are expected to reach a staggering 169 million.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

New hope for HIV cure as third patient shows signs of remission after stem cell transplant

Senior physician Björn-Erik Ole Jensen says allogeneic hematopoietic stem cell transplant is a strong answer to curing HIV-1

Manforce AIDS campaign is confused about what to market—awareness or social responsibility

In 2020, Manforce campaign asked Indians to use condoms without thinking about the brand, a clever way to build goodwill. This time it has fallen short.

New drugs mean AIDS is no longer life-limiting. But here’s why elderly will be left out

The threats and implications of HIV infection for older people are as serious as they are for younger age groups.

World AIDS Day: 57% Indians don’t use contraception, Ahmedabad ranks lowest, survey finds

The survey findings come the same day UNAIDS warns of possible '7.7 million more AIDS-related deaths' in next 10 years.

Moderna backtracks to now open Covid vaccine trial to HIV-positive people

The move came after advocacy groups pushed Moderna, noting that people with health conditions are among the most at-risk from the novel coronavirus.

On Camera

Tariffs, chips, and China — how Trump’s trade playbook affects India

Trump’s OBBB is framed to augment domestic semiconductor production and enhance trade protection, even at the expense of certain social programs such as Medicaid, food stamps, and student loans, as well as a projected ballooning federal deficit from US$2.8 to 3.3 trillion

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Indian firm joins hands with US manufacturer to locally develop all-terrain vehicles for armed forces

Under joint venture, JSW Sarbloh Motors will indigenise and manufacture TX range ATVs in Chandigarh. The first India-assembled unit is expected by early 2026.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?